Tilray Brands (TLRY) Enterprise Value (2017 - 2026)
Tilray Brands (TLRY) posted Enterprise Value of -$92.0 million for Q1 2026, up 71.69% on a QoQ basis from -$324.9 million in Q4 2025.
Tilray Brands (TLRY) Enterprise Value (2017 - 2026) Analysis & Trends
Tilray Brands' Enterprise Value history runs 10 years deep, the most recent figure standing at -$92.0 million for Q1 2026.
- Quarterly Enterprise Value changed N/A year-over-year to -$92.0 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was -$92.0 million (changed N/A YoY) and the FY2025 annual result came in at -$56.6 million, up 78.25% from the prior year.
- Enterprise Value was -$92.0 million for Q1 2026 at Tilray Brands, up from -$324.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$56.6 million in Q2 2025 and bottomed at -$452.8 million in Q3 2022.
- A 5-year average of -$268.0 million and a median of -$265.9 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value slumped 75.04% — and 2025, when it surged 78.25%.
- Tilray Brands' Enterprise Value stood at -$420.6 million in 2022, then surged by 44.19% to -$234.8 million in 2023, then retreated by 15.67% to -$271.6 million in 2024, then declined by 19.63% to -$324.9 million in 2025, then jumped by 71.69% to -$92.0 million in 2026.
- Business Quant data shows TLRY's Enterprise Value at -$92.0 million in Q1 2026, -$324.9 million in Q4 2025, and -$284.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | -91.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -91.96 Mn |
| Nov 30, 2025 | -324.87 Mn |
| Aug 31, 2025 | -284.91 Mn |
| May 31, 2025 | -56.60 Mn |
| Nov 30, 2024 | -271.57 Mn |
| Aug 31, 2024 | -274.73 Mn |
| May 31, 2024 | -260.25 Mn |
| Feb 29, 2024 | -241.68 Mn |
| Nov 30, 2023 | -234.78 Mn |
| Aug 31, 2023 | -156.95 Mn |
| May 31, 2023 | -192.38 Mn |
| Feb 28, 2023 | -405.17 Mn |
| Nov 30, 2022 | -420.63 Mn |
| Aug 31, 2022 | -452.80 Mn |
| May 31, 2022 | -373.35 Mn |
| Feb 28, 2022 | -245.44 Mn |
| Nov 30, 2021 | -295.08 Mn |
| Aug 31, 2021 | -310.01 Mn |
| May 31, 2021 | -482.22 Mn |
| May 31, 2020 | -333.69 Mn |